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Abstract 
Breast cancer can present with metastatic disease initially or as a systemic relapse 
despite seemingly adequate initial treatment. We report a case of suspected metastatic 
breast cancer to an intraabdominal lymph node based on imaging, which was 
subsequently confirmed by tissue sampling at the time of endoscopic ultrasound (EUS). 
While previous studies have shown the utility of EUS in the diagnosis of metastatic breast 
cancer, this is the first case to our knowledge that describes the use of EUS in diagnosing 
recurrent breast cancer to an intraabdominal lymph node. 
Introduction 
It is estimated that in the United States, approximately 207,000 women were diagnosed 
with invasive breast cancer and approximately 40,000 women died from the disease in 
2010 [1]. Between 1999 and 2005, 4–8% of women in the United States initially diagnosed 
with breast cancer were found to have metastatic disease [1]. The most common sites of 
breast cancer metastases are to bone, liver, brain, lung, and subcutaneous tissues. We 
report the use of endoscopic ultrasound (EUS) in establishing the diagnosis of recurrent 
breast cancer to an intraabdominal lymph node. 
Case Report 
A 43-year-old female was diagnosed with invasive ductal carcinoma (modified Bloom-Richardson 
grade III, estrogen receptor negative, progesterone receptor negative, HER2/neu negative) of the 
left breast in 2008 by needle biopsy. She subsequently completed neoadjuvant therapy with 
cyclophosphamide, doxorubicin, and fluorouracil followed by an incomplete course of paclitaxel,  
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which was discontinued prematurely due to neuropathy. At the time of left radical mastectomy, a 
2.5 cm tumor with 7 out of 30 lymph nodes positive for malignancy was found (stage IIIC). Adjuvant 
therapy with radiation and docetaxel was subsequently completed. Computed tomography (CT) scans 
after adjuvant therapy were notable for an enlarging left upper lobe lung nodule concerning for 
metastatic disease. A subsequent positron emission tomography (PET) scan approximately 11 months 
after surgery demonstrated increased uptake of the pulmonary nodule seen on CT as well as in the right 
suprarenal region, which were both concerning for metastatic disease. 
Due to the potential morbidity associated with sampling the lung nodule, EUS was requested to 
evaluate the intraabdominal finding on PET-CT. EUS demonstrated an isoechoic, well-defined 2.5 cm 
lymph node adjacent to the right kidney (fig. 1). Six passes were made with a 22 gauge fine needle 
aspiration needle under EUS guidance. The procedure duration was approximately 30 min. The patient 
tolerated the procedure well without complications and was discharged home 1 h after the procedure. 
The final cytologic impression was consistent with metastatic breast cancer with a similar 
immunohistochemical profile to the primary tumor. The patient is now receiving adjuvant carboplatin 
and gemcitabine therapy. 
Discussion 
EUS is a well-recognized technique for staging and sampling various gastrointestinal 
malignancies. However, it has also been utilized for sampling ascites, the adrenal glands, 
as well as lymph nodes surrounding the esophagus, stomach, proximal duodenum, and 
rectum to aid in the diagnosis of malignancy [2–5]. While EUS has previously been 
shown to be useful in diagnosing metastatic breast cancer to the esophagus, mediastinum, 
pancreas, stomach, and peritoneum [2–4, 6–8], there have been no reports to our 
knowledge describing the use of EUS for diagnosing an intraabdominal lymph node 
recurrence of breast cancer as in this case. Since the diagnosis of metastatic breast cancer 
was established by EUS, the patient was able to receive adjuvant therapy without 
undergoing more invasive procedures to sample the concerning pulmonary nodule. 
In conclusion, the use of EUS should be considered as a less invasive modality for 
diagnosing primary or recurrent malignancies located adjacent to the upper or lower 
gastrointestinal tract. 
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Fig. 1. EUS demonstrating an enlarged lymph node adjacent to the right kidney. Fine needle aspiration 
of the lymph node under EUS guidance demonstrated malignant cells consistent with a breast primary. 
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